Trial Profile
A Phase Ia clinical trial of IB-657 in hepatitis C-infected patients
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 20 Jun 2016
Price :
$35
*
At a glance
- Drugs CB 183872 (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- 20 Jun 2016 New trial record